INHIBIKASE THERAPEUTICS INC

CUSIP: 45719W106 Class: COM

ACT CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001442273)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022
Shares 937,500 Value ($000) $853 Avg Close — Range —
Q2 2022
Shares 937,500 Value ($000) $696 Avg Close — Range —
Q1 2022
Shares 1,076,500 Value ($000) $1,593 Avg Close — Range —
Q4 2021
Shares 1,076,500 Value ($000) $1,582 Avg Close — Range —
Q3 2021
Shares 1,010,000 Value ($000) $1,919 Avg Close — Range —
Q2 2021
Shares 875,000 Value ($000) $2,450 Avg Close — Range —